ArticleBone marrow transplantation2021

Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres.

Georgia J McCaughan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.